Global Market Study on Animal Drug Compounding: Unavailability of Generic Medicines in Desired Dosage Aiding Market Expansion

Global Market Study on Animal Drug Compounding: Unavailability of Generic Medicines in Desired Dosage Aiding Market Expansion

  • Persistence Market Research
  • January 2021
  • Healthcare
  • 265 pages

Report Description

Animal Drug Compounding Market - Scope of Report

A latest publication by Persistence Market Research on the global animal drug compounding market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the animal drug compounding market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.

Important indicators for the successful growth of the animal drug compounding market are presented in this comprehensive report, which include supply chain analysis, value chain analysis, Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which have been described in an exhaustive way in this research. This research study can support readers to know the demand for animal drug compounding and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the animal drug compounding market, including market investors, and service providers, and can help them in developing suitable business strategies to flourish in the market. The insights and wisdom presented in this Persistence Market Research study can be leveraged by shareholders in the animal drug compounding market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the animal drug compounding market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this market report, minor companies and new entrants in the animal drug compounding industry can be aided in making suitable company choices to achieve traction in the market.

Key Questions Answered in Report

  • Which regions will continue to remain most profitable regional markets for animal drug compounding?
  • Which factors will induce a change in the demand for animal drug compounding during the assessment period?
  • How will the COVID-19 pandemic change the trends of the market?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the winning strategies of stakeholders in the animal drug compounding market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and tackle while investing in market?
  • What are the developmental trends in animal drug compounding sectors that will impact the market?
  • How can businesses in the animal drug compounding market avail the growth opportunities in developed and emerging economies?

Research Methodology

In Persistence Market Research study, a unique research methodology is utilized to conduct extensive research on the growth of the animal drug compounding market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the animal drug compounding market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts interviewed specialized industry experts, medical professionals, and key executives of product manufacturing companies, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the animal drug compounding market, and makes Persistence Market Research’s projections on the growth prospects of the market more accurate and reliable.

Have query on this report?

Make an Enquiry

Table of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions

3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Method Innovation / Development Trends

4. Key Success Factors
4.1. Strategic Promotional Strategies
4.2. Key Regulations & Reimbursement 

5. Global Animal Drug Compounding Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
5.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
5.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis

6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Global Healthcare Expenditure Outlook
6.1.3. Per-Capita Healthcare Expenditure
6.2. Forecast Factors - Relevance & Impact
6.2.1. Increasing Regulatory Inspections of Animal Drug Compounding Pharmacies
6.2.2. Rising FDA Approvals 
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Trends
6.3.4. Opportunity Analysis

7. COVID19 Crisis Analysis
7.1. Current COVID-19 Statistics and Probable Future Impact
7.2. Current GDP Projection and Probable Impact
7.3. Current Economic Projection as compared to 2008 financial analysis
7.4. COVID19 and Impact Analysis
7.4.1. Revenue By Product
7.4.2. Revenue By Country
7.5. 2020 Market Scenario
7.6. Quarter by Quarter Forecast
7.7. Projected recovery Quarter
7.8. Recovery Scenario - Short term, Midterm and Long Term Impact

8. Global Animal Drug Compounding Market Analysis 2015-2019 and Forecast 2020-2030, By Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Product Type, 2015-2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020-2030
8.3.1. CNS Agents
8.3.2. Anti-Infective Agents
8.3.3. Hormones and Substitutes
8.3.4. Anti-inflammatory Agents
8.3.5. Others
8.4. Market Attractiveness Analysis By Product Type

9. Global Animal Drug Compounding Market Analysis 2015-2019 and Forecast 2020-2030, By Animal Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) By Animal Type, 2015-2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Animal Type, 2020-2030
9.3.1. Companion Animals
9.3.1.1. Dogs
9.3.1.2. Cats
9.3.1.3. Others
9.3.2. Livestock Animals
9.4. Market Attractiveness Analysis By Animal Type

10. Global Animal Drug Compounding Market Analysis 2015-2019 and Forecast 2020-2030, By Formulation
10.1.   Introduction / Key Findings
10.2.   Historical Market Size (US$ Mn) By Formulation, 2015-2019
10.3.   Current and Future Market Size (US$ Mn)) Analysis and Forecast By Formulation, 2020-2030
10.3.1. Oral
10.3.2. Injectable
10.3.3. Others
10.4. Market Attractiveness Analysis By Formulation

11. Global Animal Drug Compounding Market Analysis 2015-2019 and Forecast 2020-2030, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region

12. North America Animal Drug Compounding Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
12.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2020-2030
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product Type
12.3.3. By Animal Type
12.3.4. By Formulation
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis

13. Latin America Animal Drug Compounding Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
13.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2020-2030
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.1. By Product Type
13.3.2. By Animal Type
13.3.3. By Formulation
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis

14. Europe Animal Drug Compounding Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
14.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy2020-2030
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.1. By Product Type
14.3.2. By Animal Type
14.3.3. By Formulation
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis

15. South Asia Animal Drug Compounding Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
15.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy2020-2030
15.3.1.  By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.1. By Product Type
15.3.2. By Animal Type
15.3.3. By Formulation
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis

16. East Asia Animal Drug Compounding Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
16.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020-2030
16.3.1.  By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.1. By Product Type
16.3.2. By Animal Type
16.3.3. By Formulation
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis

17. Oceania Animal Drug Compounding Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
17.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020-2030
17.3.1.  By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.1. By Product Type
17.3.2. By Animal Type
17.3.3. By Formulation
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Animal Drug Compounding Market Analysis 2015-2019 and  Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
18.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020-2030
18.3.1.  By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.1. By Product Type
18.3.2. By Animal Type
18.3.3. By Formulation
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis

19. Key Countries Animal Drug Compounding Market Analysis 2015-2019 and Forecast 2020-2030
19.1. U.S. Animal Drug Compounding Market Analysis
19.1.1. By Product Type
19.1.2. By Animal Type
19.1.3. By Formulation
19.2. Canada Animal Drug Compounding Market Analysis
19.2.1. By Product Type
19.2.2. By Animal Type
19.2.3. By Formulation
19.3. Brazil Animal Drug Compounding Market Analysis
19.3.1. By Product Type
19.3.2. By Animal Type
19.3.3. By Formulation
19.4. Mexico Animal Drug Compounding Market Analysis
19.4.1. By Product Type
19.4.2. By Animal Type
19.4.3. By Formulation
19.5. Argentina Animal Drug Compounding Market Analysis
19.5.1. By Product Type
19.5.2. By Animal Type
19.5.3. By Formulation
19.6. U.K. Animal Drug Compounding Market Analysis
19.6.1. By Product Type
19.6.2. By Animal Type
19.6.3. By Formulation
19.7. Germany Animal Drug Compounding Market Analysis
19.7.1. By Product Type
19.7.2. By Animal Type
19.7.3. By Formulation
19.8. France Animal Drug Compounding Market Analysis
19.8.1. By Product Type
19.8.2. By Animal Type
19.8.3. By Formulation
19.9. Italy Animal Drug Compounding Market Analysis
19.9.1. By Product Type
19.9.2. By Animal Type
19.9.3. By Formulation
19.10.Spain Animal Drug Compounding Market Analysis
19.10.1. By Product Type
19.10.2. By Animal Type
19.10.3. By Formulation
19.11.   BENELUX Animal Drug Compounding Market Analysis
19.11.1. By Product Type
19.11.2. By Animal Type
19.11.3. By Formulation
19.12.   Russia Animal Drug Compounding Market Analysis
19.12.1. By Product Type
19.12.2. By Animal Type
19.12.3. By Formulation
19.13.   Japan Animal Drug Compounding Market Analysis
19.13.1. By Product Type
19.13.2. By Animal Type
19.13.3. By Formulation
19.14.   China Animal Drug Compounding Market Analysis
19.14.1. By Product Type
19.14.2. By Animal Type
19.14.3. By Formulation
19.15.   South Korea Animal Drug Compounding Market Analysis
19.15.1. By Product Type
19.15.2. By Animal Type
19.15.3. By Formulation
19.16.   India Animal Drug Compounding Market Analysis
19.16.1. By Product Type
19.16.2. By Animal Type
19.16.3. By Formulation
19.17.   ASEAN Animal Drug Compounding Market Analysis
19.17.1. By Product Type
19.17.2. By Animal Type
19.17.3. By Formulation
19.18.   Australia Animal Drug Compounding Market Analysis
19.18.1. By Product Type
19.18.2. By Animal Type
19.18.3. By Formulation
19.19.   New Zealand Animal Drug Compounding Market Analysis
19.19.1. By Product Type
19.19.2. By Animal Type
19.19.3. By Formulation
19.20.   GCC Countries Animal Drug Compounding Market Analysis
19.20.1. By Product Type
19.20.2. By Animal Type
19.20.3. By Formulation
19.21.   Turkey Animal Drug Compounding Market Analysis
19.21.1. By Product Type
19.21.2. By Animal Type
19.21.3. By Formulation
19.22.   South Africa Animal Drug Compounding Market Analysis
19.22.1. By Product Type
19.22.2. By Animal Type
19.22.3. By Formulation

20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies 
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1.1. Regional footprint of Players
20.4.1.2. Method foot print by Players
20.4.1.3. Channel Foot Print by Players

21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive 
21.3.1. Hoye's Pharmacy
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Profitability by Market Segments (Product/End User/Region)
21.3.1.4. Sales Footprint
21.3.1.5. Strategy Overview
21.3.1.5.1. Marketing Strategy
21.3.1.5.2. Product Strategy
21.3.1.5.3. Channel Strategy
21.3.2. Vertisis Custom Pharmacy
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Profitability by Market Segments (Product/End User/Region)
21.3.2.4. Sales Footprint
21.3.2.5. Strategy Overview
21.3.2.5.1. Marketing Strategy
21.3.2.5.2. Product Strategy
21.3.2.5.3. Channel Strategy
21.3.3. Smith Caldwell Drug Store
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Profitability by Market Segments (Product/End User/Region)
21.3.3.4. Sales Footprint
21.3.3.5. Strategy Overview
21.3.3.5.1. Marketing Strategy
21.3.3.5.2. Product Strategy
21.3.3.5.3. Channel Strategy
21.3.4. Sixth Avenue Medical Pharmacy
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Profitability by Market Segments (Product/End User/Region)
21.3.4.4. Sales Footprint
21.3.4.5. Strategy Overview
21.3.4.5.1. Marketing Strategy
21.3.4.5.2. Product Strategy
21.3.4.5.3. Channel Strategy
21.3.5. Dougherty's Pharmacy
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Profitability by Market Segments (Product/End User/Region)
21.3.5.4. Sales Footprint
21.3.5.5. Strategy Overview
21.3.5.5.1. Marketing Strategy
21.3.5.5.2. Product Strategy
21.3.5.5.3. Channel Strategy
21.3.6. Triangle Compounding Pharmacy Inc.
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Profitability by Market Segments (Product/End User/Region)
21.3.6.4. Sales Footprint
21.3.6.5. Strategy Overview
21.3.6.5.1. Marketing Strategy
21.3.6.5.2. Product Strategy
21.3.6.5.3. Channel Strategy
21.3.7. Medisca Inc.
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Profitability by Market Segments (Product/End User/Region)
21.3.7.4. Sales Footprint
21.3.7.5. Strategy Overview
21.3.7.5.1. Marketing Strategy
21.3.7.5.2. Product Strategy
21.3.7.5.3. Channel Strategy
21.3.8. Wedgewood Pharmacy
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Profitability by Market Segments (Product/End User/Region)
21.3.8.4. Sales Footprint
21.3.8.5. Strategy Overview
21.3.8.5.1. Marketing Strategy
21.3.8.5.2. Product Strategy
21.3.8.5.3. Channel Strategy
21.3.9. Millers Pharmacy
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Profitability by Market Segments (Product/End User/Region)
21.3.9.4. Sales Footprint
21.3.9.5. Strategy Overview
21.3.9.5.1. Marketing Strategy
21.3.9.5.2. Product Strategy
21.3.9.5.3. Channel Strategy
21.3.10. Chiron Compounding Pharmacy
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Profitability by Market Segments (Product/End User/Region)
21.3.10.4. Sales Footprint
21.3.10.5. Strategy Overview
21.3.10.5.1. Marketing Strategy
21.3.10.5.2. Product Strategy
21.3.10.5.3. Channel Strategy
21.3.11. MEDS Canadian Compounding Pharmacy
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Profitability by Market Segments (Product/End User/Region)
21.3.11.4. Sales Footprint
21.3.11.5. Strategy Overview
21.3.11.5.1. Marketing Strategy
21.3.11.5.2. Product Strategy
21.3.11.5.3. Channel Strategy
21.3.12. Aurora Compounding
21.3.12.1. Overview
21.3.12.2. Product Portfolio
21.3.12.3. Profitability by Market Segments (Product/End User/Region)
21.3.12.4. Sales Footprint
21.3.12.5. Strategy Overview
21.3.12.5.1. Marketing Strategy
21.3.12.5.2. Product Strategy
21.3.12.5.3. Channel Strategy
21.3.13. Pace Pharmacy
21.3.13.1. Overview
21.3.13.2. Product Portfolio
21.3.13.3. Profitability by Market Segments (Product/End User/Region)
21.3.13.4. Sales Footprint
21.3.13.5. Strategy Overview
21.3.13.5.1. Marketing Strategy
21.3.13.5.2. Product Strategy
21.3.13.5.3. Channel Strategy
21.3.14. Victoria Compounding Pharmacy
21.3.14.1. Overview
21.3.14.2. Product Portfolio
21.3.14.3. Profitability by Market Segments (Product/End User/Region)
21.3.14.4. Sales Footprint
21.3.14.5. Strategy Overview
21.3.14.5.1. Marketing Strategy
21.3.14.5.2. Product Strategy
21.3.14.5.3. Channel Strategy
21.3.15. Pratt’s Compounding Pharmacy
21.3.15.1. Overview
21.3.15.2. Product Portfolio
21.3.15.3. Profitability by Market Segments (Product/End User/Region)
21.3.15.4. Sales Footprint
21.3.15.5. Strategy Overview
21.3.15.5.1. Marketing Strategy
21.3.15.5.2. Product Strategy
21.3.15.5.3. Channel Strategy
21.3.16. People’s Choice Pharmacy
21.3.16.1. Overview
21.3.16.2. Product Portfolio
21.3.16.3. Profitability by Market Segments (Product/End User/Region)
21.3.16.4. Sales Footprint
21.3.16.5. Strategy Overview
21.3.16.5.1. Marketing Strategy
21.3.16.5.2. Product Strategy
21.3.16.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

 

List of Table

Table 01: 503A and 503B Pharmacy Comparative Analysis
Table 02: Global Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020 – 2030, By Product Type
Table 03: Global Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Animal Type
Table 04: Global Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Formulation
Table 05: Global Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Region 
Table 06: North America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Country
Table 07: North America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Product Type
Table 08: North America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Animal Type
Table 09: North America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Formulation
Table 10: Latin America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Country
Table 11: Latin America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Product Type
Table 12: Latin America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Animal Type
Table 13: Latin America Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Formulation
Table 14: Europe Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Country
Table 15: Europe Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Product Type
Table 16: Europe Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Animal Type
Table 17: Europe Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Formulation
Table 18: East Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Country
Table 19: East Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Product Type
Table 20: East Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Animal Type
Table 21: East Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Formulation
Table 22: South Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Country
Table 23: South Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Product Type
Table 24: South Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Animal Type
Table 25: South Asia Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Formulation
Table 26: Oceania Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Country
Table 27: Oceania Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Product Type
Table 28: Oceania Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Animal Type
Table 29: Oceania Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Formulation
Table 30: MEA Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Country
Table 31: MEA Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Product Type
Table 32: MEA Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Animal Type
Table 33: MEA Animal Drug Compounding Market Value (US$ Mn) Analysis for 2015-2019, Estimate for 2019 and Forecast for 2020-2030, By Formulation

Success Stories

Our Clients